University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Teresa M. Darragh, M.D.

Pathologist

Dr. Teresa M. Darragh is a pathologist who sees patients in the Cytology Service and Dysplasia Clinic. She specializes in human papilloma virus (HPV) induced anogenital neoplasia, which includes cervical and anal cancer. She is involved in research investigating HPV-related anogenital tract disease in men and women. UCSF's team of experts has been fundamental in the recognition of anal HPV-related disease and the acceptance of anal cytology as a screening tool for HPV at-risk populations.

Darragh received an medical degree at Cornell University Medical College in New York. She completed a pathology residency, followed by fellowships in surgical pathology and cytopathology at UCSF. Darragh is a member of several professional organizations, including the American Society of Clinical Pathologists, Papanicolaou Society of Cytopathology, American Society of Cytopathology, American Society for Colposcopy and Cervical Pathology (ASCCP), and the College of American Pathologists. She has received numerous honors and awards, including ASCCP's Meritorious Award of Scientific Achievement. She is a professor of clinical pathology at UCSF.

Clinics

Dysplasia Clinic
1600 Divisadero St., Fourth Floor
San Francisco, CA 94143
Phone: (415) 353- 7100
Fax: (415) 353- 4298

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Teresa M. Darragh

Education

Cornell University 1986

Residencies

UCSF, Pathology 1988

Fellowships

UCSF, Cytopathology 1990
UCSF, Surgical Pathology 1991

Selected Research and Publications

  1. Crothers BA, Booth CN, Darragh TM, Zhao C, Souers RJ, Thomas N, Moriarty AT. False-Positive Papanicolaou (PAP) Test Rates in the College of American Pathologists PAP Education and PAP Proficiency Test Programs: Evaluation of False-Positive Responses of High-Grade Squamous Intraepithelial Lesion or Cancer to a Negative Reference Diagnosis. Arch Pathol Lab Med. 2014 May; 138(5):613-9.
  2. Darragh TM, Wilbur DC. Letter to the editor - reply. J Low Genit Tract Dis. 2014 Apr; 18(2):E64-5.
  3. Massad LS, Xie X, Minkoff H, Darragh TM, D'Souza G, Sanchez-Keeland L, Watts DH, Colie C, Strickler HD. Abnormal Pap Tests and Human Papillomavirus Infections Among HIV-Infected and Uninfected Women Who Have Sex With Women. J Low Genit Tract Dis. 2014 Jan; 18(1):50-6.
  4. Sharma R, Efird JT, Chein A, Holly EA, Krajden M, Berry JM, Darragh TM, Jay N, Palefsky JM. Prevalence and Risk Factors for Neutralizing Antibodies to Human Papillomavirus Types 16 and 18 in HIV-Positive Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2013 Dec 15; 64(5):479-87.
  5. Darragh TM, Winkler B, Souers RJ, Laucirica R, Zhao C, Moriarty AT. Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology. Arch Pathol Lab Med. 2013 Nov; 137(11):1550-4.
  6. Massad LS, Pierce CB, Minkoff H, Watts DH, Darragh TM, Sanchez-Keeland L, Wright RL, Colie C, D'Souza G. Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: Impact of HIV infection. Int J Cancer. 2014 Apr 15; 134(8):1854-61.
  7. Berry JM, Jay N, Cranston RD, Darragh TM, Holly EA, Welton ML, Palefsky JM. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2014 Mar 1; 134(5):1147-55.
  8. Howell LP, Darragh TM, Souers RJ, Thomas N, Moriarty AT. Identification of Trichomonas vaginalis in different Papanicolaou test preparations: trends over time in the College of American Pathologists educational Interlaboratory Comparison Program. Arch Pathol Lab Med. 2013 Aug; 137(8):1043-6.
  9. Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N. Risk Factors for Anal HPV Infection and Anal Precancer in HIV-Infected Men Who Have Sex With Men. J Infect Dis. 2013 Dec; 208(11):1768-75.
  10. Hessol NA, Holly EA, Efird JT, Minkoff H, Weber KM, Darragh TM, Burk RD, Strickler HD, Greenblatt RM, Palefsky JM. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS. 2013 Jul 17; 27(11):1743-51.
  11. Moscicki AB, Ma Y, Farhat S, Darragh TM, Pawlita M, Galloway DA, Shiboski S. Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16. J Infect Dis. 2013 Aug 1; 208(3):403-12.
  12. Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, Da Costa M, Panther L, Aboulafia D, Palefsky JM. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women. AIDS. 2013 Feb 20; 27(4):545-51.
  13. Wilbur DC, Darragh TM. Harmony at LAST. Cancer Cytopathol. 2013 Mar; 121(3):111-5.
  14. Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013 Jan; 32(1):76-115.
  15. Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012 Dec; 120(6):1465-71.
  16. Darragh TM, Winkler B. Screening for anal neoplasia: anal cytology - sampling, processing and reporting. Sex Health. 2012 Dec; 9(6):556-61.
  17. Sahasrabuddhe VV, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere BJ, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Wentzensen N. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis. 2013 Feb 1; 207(3):392-401.
  18. Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere B, Gage JC, Fetterman B, Darragh TM, Rodriguez AC, Wentzensen N. A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):42-9.
  19. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS. 2012 Nov 13; 26(17):2185-92.
  20. Crothers BA, Booth CN, Darragh TM, Means MM, Souers RJ, Thomas N, Moriarty AT. Atrophic vaginitis: concordance and interpretation of slides in the College of American Pathologists Cervicovaginal Interlaboratory Comparison Program in Gynecologic Cytopathology. Arch Pathol Lab Med. 2012 Nov; 136(11):1332-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.